# Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis

> **NCT02229747** · PHASE4 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 128 (actual)

## Conditions studied

- Pharyngitis

## Interventions

- **DRUG:** Meloxicam
- **DRUG:** Diclofenac
- **DRUG:** Nimesulide

## Key facts

- **NCT ID:** NCT02229747
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2002-02
- **Final completion:** —
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2014-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229747, "Efficacy and Safety of Meloxicam Suspension Versus Diclofenac Suspension or Nimesulide Suspension in Patients With a Diagnosis of Acute, Non-bacterial Pharyngitis, Pharyngotonsillitis or Laryngitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02229747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*